 |
Alpha-1-antitrypsin (recombinant DNA Origin) |
|---|---|
| Trade Name | |
| Orphan Indication | As supplementation therapy for alpha-1-antitrypsin deficiency in the ZZ phenotype population |
| USA Market Approval | USA |
| USA Designation Date | 1984-01-01 00:00:00 |
| Sponsor | Chiron Corporation;4560 Horton Street;Emeryville, California, 94608 |
